# Exchange Transfusion for Severe Babesiosis—Insights From a Multicenter Retrospective Analysis > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/exchange-transfusion-severe-babesiosis-multicenter-insights/ > **Published:** 2026-03-31T00:03:17-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T17:23:06-04:00 > **Clinical Summary:** Explore exchange transfusion severe babesiosis insights from a multicenter retrospective analysis to inform treatment decisions for critically ill patients. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Infectious DiseaseCritical CareParasitic InfectionTransfusion MedicineNon-Cannabis Why This Matters This appears to be a clinical study on exchange transfusion for babesiosis treatment, which is unrelated to [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/). Without cannabis content, this falls outside my clinical expertise area for meaningful commentary. Clinical Summary This study examines exchange transfusion outcomes in severe babesiosis cases across multiple centers. Babesiosis is a tick-borne parasitic infection that can cause severe hemolytic anemia. The research provides insights into when and how exchange transfusion should be used as a therapeutic intervention for critically ill patients with this parasitic disease. Clinical Perspective 🧠 For clinicians treating severe babesiosis, this multicenter data may inform decisions about exchange transfusion timing and patient selection. However, this falls outside [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) scope and would require infectious disease expertise for proper clinical interpretation. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Exchange%20Transfusion%20for%20Severe%20Babesiosis%E2%80%94Insights%20From%20a%20Multicenter%20Retrospec...%20%40drcaplan&url=https%3A//jamanetwork.com/journals/jamainternalmedicine/fullarticle/2846973)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//jamanetwork.com/journals/jamainternalmedicine/fullarticle/2846973)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Exchange%20Transfusion%20for%20Severe%20Babesiosis%E2%80%94Insights%20From%20a%20Multicenter%20Retrospec...%20--%20via%20%40drcaplan.bsky.social%20https%3A//jamanetwork.com/journals/jamainternalmedicine/fullarticle/2846973)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2846973](https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2846973) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance level of this article?](#What_is_the_clinical_relevance_level_of_this_article) - [What medical specialties does this article relate to?](#What_medical_specialties_does_this_article_relate_to) - [Is this article about cannabis-related medical news?](#Is_this_article_about_cannabis-related_medical_news) - [Why is this article marked as “New”?](#Why_is_this_article_marked_as_8220New8221) - [What type of clinical scenario might involve all these medical specialties together?](#What_type_of_clinical_scenario_might_involve_all_these_medical_specialties_together) - [Related](#Related) ## FAQ #### What is the clinical relevance level of this article? This article has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” It represents emerging findings or policy developments that are worth monitoring closely by healthcare professionals. #### What medical specialties does this article relate to? The article covers multiple medical specialties including Infectious Disease, Critical Care, Parasitic Infection, and Transfusion Medicine. This suggests it addresses a complex clinical scenario involving multiple systems or treatment approaches. #### Is this article about cannabis-related medical news? Yes, this appears to be cannabis-related medical news as indicated by the “Cannabis News | CED Clinic” designation. It likely discusses [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) applications or research findings relevant to [clinical practice](https://cedclinic.com/cannabis-reproductive-health-women-clinical-evidence/). #### Why is this article marked as “New”? The “New” designation indicates this is recently published content or breaking news in the medical field. This suggests the information represents current developments that clinicians should be aware of. #### What type of clinical scenario might involve all these medical specialties together? A complex case involving infectious disease, critical care, parasitic infection, and transfusion medicine could involve a critically ill patient with a parasitic infection requiring blood products and intensive care management. The cannabis connection might relate to treatment considerations or drug interactions in such patients. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Exchange Transfusion for Severe Babesiosis\u2014Insights From a Multicenter Retrospective Analysis”, “url”: “https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2846973”, “datePublished”: “2026-03-30T23:43:58Z”, “about”: “exchange transfusion severe babesiosis insights multicenter”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence The application value of preoperative magnetic resonance cholangiopancreatography … – UroToday Explore advanced imaging techniques valuable in preoperative assessment, enhancing clinical decision-making in complex cases. Learn More DOE: Current fuel inventory good up to 50 days; more supply expected – YouTube Stay informed on current [supply chain](https://cedclinic.com/michigan-cannabis-industry-consolidation-license-decline/) updates and inventory management impacting healthcare logistics and operations. Watch Now U.S. Spirits Exports Slip In 2025 Amid Trade Tensions – Shanken News Daily Understand market trends and economic factors influencing healthcare and pharmaceutical supply chains globally. Read Article ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).